Cargando…

Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds

Echinococcosis is a serious helminthic zoonosis with a great impact on human health and livestock husbandry. However, the clinically used drugs (benzimidazoles) have a low cure rate, so alternative drugs are urgently needed. Currently, drug screenings for echinococcosis are mainly phenotype-based, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Congshan, Yin, Jianhai, Yao, Jiaqing, Xu, Zhijian, Tao, Yi, Zhang, Haobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098963/
https://www.ncbi.nlm.nih.gov/pubmed/32266168
http://dx.doi.org/10.3389/fcimb.2020.00118
_version_ 1783511258865074176
author Liu, Congshan
Yin, Jianhai
Yao, Jiaqing
Xu, Zhijian
Tao, Yi
Zhang, Haobing
author_facet Liu, Congshan
Yin, Jianhai
Yao, Jiaqing
Xu, Zhijian
Tao, Yi
Zhang, Haobing
author_sort Liu, Congshan
collection PubMed
description Echinococcosis is a serious helminthic zoonosis with a great impact on human health and livestock husbandry. However, the clinically used drugs (benzimidazoles) have a low cure rate, so alternative drugs are urgently needed. Currently, drug screenings for echinococcosis are mainly phenotype-based, and the efficiency of identifying active compounds is very low. With a pharmacophore model generated from the structures of active amino alcohols, we performed a virtual screening to discover novel compounds with anti-echinococcal activity. Sixty-two compounds from the virtual screening were tested on Echinococcus multilocularis protoscoleces, and 10 of these compounds were found to be active. After further evaluation of their cytotoxicity, S6 was selected along with two active amino alcohols for in vivo pharmacodynamic and pharmacokinetic studies. At the two tested doses (50 and 25 mg/kg), S6 inhibited the growth of E. multilocularis in mice (14.43 and 9.53%), but no significant difference between the treatment groups and control group was observed. Treatment with BTB4 and HT3 was shown to be ineffective. During the 28 days of treatment, the death of mice in the mebendazole, HT3, and BTB4 groups indicated their toxicity. The plasma concentration of S6 administered by both methods was very low, with the C(max) being only 1 ng/ml after oral administration and below the detection limit after intramuscular administration. In addition, the plasma concentrations of BTB4 and HT3 in vitro did not reach high enough levels to kill the parasites. The toxicities of these two amino alcohols indicated that they are not suitable for further development as anti-echinococcal drugs. However, further attempts should be made to increase the bioavailability of S6 and modify its structure. In this study, we demonstrate that pharmacophore-based virtual screenings with high drug identification efficiency could be used to find novel drugs for treating echinococcosis.
format Online
Article
Text
id pubmed-7098963
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70989632020-04-07 Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds Liu, Congshan Yin, Jianhai Yao, Jiaqing Xu, Zhijian Tao, Yi Zhang, Haobing Front Cell Infect Microbiol Cellular and Infection Microbiology Echinococcosis is a serious helminthic zoonosis with a great impact on human health and livestock husbandry. However, the clinically used drugs (benzimidazoles) have a low cure rate, so alternative drugs are urgently needed. Currently, drug screenings for echinococcosis are mainly phenotype-based, and the efficiency of identifying active compounds is very low. With a pharmacophore model generated from the structures of active amino alcohols, we performed a virtual screening to discover novel compounds with anti-echinococcal activity. Sixty-two compounds from the virtual screening were tested on Echinococcus multilocularis protoscoleces, and 10 of these compounds were found to be active. After further evaluation of their cytotoxicity, S6 was selected along with two active amino alcohols for in vivo pharmacodynamic and pharmacokinetic studies. At the two tested doses (50 and 25 mg/kg), S6 inhibited the growth of E. multilocularis in mice (14.43 and 9.53%), but no significant difference between the treatment groups and control group was observed. Treatment with BTB4 and HT3 was shown to be ineffective. During the 28 days of treatment, the death of mice in the mebendazole, HT3, and BTB4 groups indicated their toxicity. The plasma concentration of S6 administered by both methods was very low, with the C(max) being only 1 ng/ml after oral administration and below the detection limit after intramuscular administration. In addition, the plasma concentrations of BTB4 and HT3 in vitro did not reach high enough levels to kill the parasites. The toxicities of these two amino alcohols indicated that they are not suitable for further development as anti-echinococcal drugs. However, further attempts should be made to increase the bioavailability of S6 and modify its structure. In this study, we demonstrate that pharmacophore-based virtual screenings with high drug identification efficiency could be used to find novel drugs for treating echinococcosis. Frontiers Media S.A. 2020-03-20 /pmc/articles/PMC7098963/ /pubmed/32266168 http://dx.doi.org/10.3389/fcimb.2020.00118 Text en Copyright © 2020 Liu, Yin, Yao, Xu, Tao and Zhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Liu, Congshan
Yin, Jianhai
Yao, Jiaqing
Xu, Zhijian
Tao, Yi
Zhang, Haobing
Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds
title Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds
title_full Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds
title_fullStr Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds
title_full_unstemmed Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds
title_short Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds
title_sort pharmacophore-based virtual screening toward the discovery of novel anti-echinococcal compounds
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098963/
https://www.ncbi.nlm.nih.gov/pubmed/32266168
http://dx.doi.org/10.3389/fcimb.2020.00118
work_keys_str_mv AT liucongshan pharmacophorebasedvirtualscreeningtowardthediscoveryofnovelantiechinococcalcompounds
AT yinjianhai pharmacophorebasedvirtualscreeningtowardthediscoveryofnovelantiechinococcalcompounds
AT yaojiaqing pharmacophorebasedvirtualscreeningtowardthediscoveryofnovelantiechinococcalcompounds
AT xuzhijian pharmacophorebasedvirtualscreeningtowardthediscoveryofnovelantiechinococcalcompounds
AT taoyi pharmacophorebasedvirtualscreeningtowardthediscoveryofnovelantiechinococcalcompounds
AT zhanghaobing pharmacophorebasedvirtualscreeningtowardthediscoveryofnovelantiechinococcalcompounds